HAS three-lens brief
Evidence-based stock research on HAS. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Underperforming SPY by 12.0pp over 30 days. · Trading >3% below the 50-day MA — short-term weakness.
- Trading >3% below the 50-day MA — short-term weakness.
- Underperforming SPY by 12.0pp over 30 days.
- Analyst mean target $112.29 — 44% above current (14 analysts).
- Debt-to-equity of 574% — balance-sheet-heavy.
- Earnings scheduled 2026-07-21.
HAS closed at $77.74 (+0.45%) as of 2026-07-10. Market cap: $11.00B. Price is below the 50-day MA and below the 200-day MA. Positives: analyst mean target $112.29 — 44% above current (14 analysts).. Concerns: trading >3% below the 50-day MA — short-term weakness.; underperforming SPY by 12.0pp over 30 days.. Last quarter: Revenue $1.00B, net income $198.40M, free cash flow $547.92M. Watching for: 2026-07-21 earnings release (10 days out).
Why three lenses on HAS, not one.
A single reasoning model has blind spots it doesn’t know about. We examine HASacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/HAS" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath HAS brief"></iframe>